help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bikle, D. D.
Right arrow Articles by Hincenbergs, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bikle, D. D.
Right arrow Articles by Hincenbergs, M.

Endocrinology, Vol 124, 655-660, Copyright © 1989 by Endocrine Society


ARTICLES

Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma

DD Bikle, S Pillai, E Gee and M Hincenbergs
Veterans Administration Medical Center, San Francisco, California 94121.

Interferon-gamma (IFN gamma) and 1,25-dihydroxyvitamin D [1,25-(OH)2D] each have potent antiproliferative and prodifferentiating effects on keratinocytes. Since keratinocytes produce 1,25-(OH)2D, we explored the possibility that IFN gamma acted on keratinocytes in part by regulating 1,25-(OH)2D production. We cultured human neonatal foreskin keratinocytes for various periods of time in the presence of various concentrations of IFN gamma before assessing their ability to produce 1,25-(OH)2D. The production of 1,25-(OH)2D by preconfluent keratinocytes grown in the presence of serum (which retards differentiation) was stimulated by 1.8 nM IFN gamma. Postconfluent keratinocytes did not respond to 1.8 nM IFN gamma. The production of 1,25-(OH)2D by keratinocytes grown in serum-free medium was maximally stimulated by 0.006 nM IFN gamma and inhibited at concentrations greater than 0.06 nM. Keratinocytes grown in 0.1 mM calcium serum-free medium (which prevents differentiation) were more sensitive to both the stimulatory and inhibitory effects of IFN gamma than keratinocytes grown in 1.2 mM calcium serum-free medium (which permits differentiation). The stimulatory effect of IFN gamma on 1,25-(OH)2D production was maximal after 2 days of incubation. Incubations longer than 2 days showed increasingly less stimulation at the low IFN gamma concentrations and increasingly greater inhibition at the higher IFN gamma concentrations. The inhibitory effects of IFN gamma on 1,25- (OH)2D production paralleled the inhibitory effects of IFN gamma on cell growth. Thus, IFN gamma does regulate 1,25-(OH)2D production by keratinocytes. However, this regulation is modulated by the state of keratinocyte proliferation and differentiation and is influenced by calcium and undefined factors in serum. The data are consistent with the possibility that IFN gamma alters keratinocyte differentiation in part by regulating 1,25-(OH)2D production.


This article has been cited by other articles:


Home page
J. Nutr.Home page
D. D. Bikle
Vitamin D and Skin Cancer
J. Nutr., December 1, 2004; 134(12): 3472S - 3478S.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Zehnder, R. Bland, M. C. Williams, R. W. McNinch, A. J. Howie, P. M. Stewart, and M. Hewison
Extrarenal Expression of 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 888 - 894.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. Jones, H. Ramshaw, A. Zhang, R. Cook, V. Byford, J. White, and M. Petkovich
Expression and Activity of Vitamin D-Metabolizing Cytochrome P450s (CYP1{alpha} and CYP24) in Human Nonsmall Cell Lung Carcinomas
Endocrinology, July 1, 1999; 140(7): 3303 - 3310.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society